17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Are you thinking about starting your own construction business? If so, whether in the commercial or ...
Read More >
Wall Street had another come-to-Jesus day over the troubling recent Covid trends, as surging cases t...
Read More >
Foreign pursuit of the local market - If a foreign designer or contractor wanted to set up an oper...
Read More >
The SEC announced settled charges against Andeavor LLC for controls violations relating to a stock b...
Read More >
While Delaware’s “stay at home” order remains in place amid the COVID-19 pandemic, the Delaware S...
Read More >
Last June, Governor Lamont signed into law the “Time’s Up Act” (P.A. 19-16), which significantly ...
Read More >